3-pentylbenzeneacetic acid sodium salt | |
---|---|
Trade Name | |
Orphan Indication | Alström syndrome |
USA Market Approval | USA |
USA Designation Date | 2017-02-28 00:00:00 |
Sponsor | ProMetic BioTherapeutics, Inc;1330 Piccard Drive, Suite 201;Rockville, Maryland, 20850 |